Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg versus other long-acting reversible contraceptives for contraception in Spain.
José C Quílez CondeInmaculada Parra RibesJosep Perelló-CapoPaloma Lobo AbascalIgnacio Cristóbal GarcíaMercedes Andeyro GarcíaJosé Gutiérrez AlésMercedes Herrero CondeJoan Rius TarruellaBelén Espinós LafuentePublished in: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2024)
) uptake in contraception could generate further cost savings for the Spanish NHS and reduce economic burden of UP.
Keyphrases